MedTech
Turn clinical innovation
into market adoption
Great MedTech products do not succeed on clinical value alone.
North American growth depends on reaching the right surgeons, clinical stakeholders and treatment centers — and giving every customer-facing team the insight to engage them credibly.
A differentiated device may solve a real clinical problem. But adoption still happens one surgeon, one center and one conversation at a time. That requires more than broad specialty lists, generic campaigns or product messaging.
The product should be differentiated.
The go-to-market must make that difference relevant.
THE CHALLENGE
As MedTech companies expand, commercial execution becomes more complex
But the knowledge needed to support that growth is often fragmented.
Clinical evidence sits in one place. Approved claims in another. Product expertise with marketing. Surgeon relationships with faculty, reps and distributors. Market and account knowledge across different teams and systems.
At the same time, teams need to understand which surgeons are most relevant, what procedures they perform, where they operate, who influences them, which technologies they use and which clinical questions matter to them.
Too much of that context still has to be researched and reconstructed before each interaction..
➜ The result is often disconnected targeting, messaging and engagement rather than one coordinated commercial engine.
More surgeons.
More treatment centers.
More clinical stakeholders.
More markets.
More distributors.
More data and signals.
PangeaGTM FOR MEDTECH
Connect market intelligence, clinical knowledge and commercial execution
Turn initial adoption into broader market presence.
Carry what you learn from individual surgeons and centers into the next stage of growth.Identify additional surgeons, sites, clinical networks and geographies with similar potential. Support reps and distributors with the same intelligence and messaging foundation as your direct team. Build from first conversations to first cases — and from individual adoption to repeatable market expansion.
Build relevance before launch - Find the surgeons and centers with the strongest potential - Carry what you learn from every interaction into the next conversation, campaign, market and growth opportunity.
PangeaGTM connects the parts of the MedTech go-to-market lifecycle where relevance has the greatest impact.
Find the surgeons and centers that matter most.
Move beyond broad specialty lists. Combine procedure focus, clinical interests, CPT and procedure signals, treatment-center context, professional networks, KOL relationships and other market indicators to identify and prioritize the most relevant targets. Focus commercial resources where adoption potential is strongest.
Build relevance before the commercial conversation begins.
Engage priority surgeons around the clinical topics, procedures and challenges that matter to them. Use relevant market signals, clinical content, faculty activity and professional engagement to create familiarity before a direct sales conversation. Build a warmer pipeline before launch - and keep target surgeons engaged as the market develops.
Turn engagement into qualified commercial opportunities.
Give marketing, market development, sales and commercial leadership a shared understanding of each surgeon, center and opportunity. Know who has engaged, what matters to them, which next step is appropriate and where the strongest adoption potential exists. Move from outreach activity toward qualified conversations, meetings, evaluations and first cases.
Prepare better surgeon conversations.
Bring together surgeon context, practice and center insight, procedure signals, clinical evidence, approved claims, competitive intelligence and company knowledge. Give reps, distributors and commercial teams a relevant brief before every important interaction. Understand the surgeon's world before the conversation starts — rather than asking the surgeon to educate you during it.
Make your clinical and commercial difference relevant.
Clinical evidence matters. So does understanding which part of that evidence matters to a particular surgeon, procedure or care setting. Connect product strengths, approved claims, clinical outcomes and competitive differentiation to the individual context of the customer. Keep customer-facing engagement aligned with your approved messaging while allowing teams to communicate with greater relevance.
HOW
Clinical and commercial relevance at scale
➜ And turns them into relevant action
across your go-to-market.
Insight becomes action.
Knowledge becomes reusable.
Relevance becomes scalable.
From identifying the right surgeon, to preparing the next meeting, creating relevant messaging or expanding into a new market.
PangeaGTM brings together:
Every customer interaction has an on-stage moment - and a backstage intelligence.
The conversation is what the customer sees. But what makes that conversation relevant happens behind the scenes. PangeaGTM connects the clinical, market and commercial knowledge behind every interaction — so customer-facing teams can engage with greater context, consistency and confidence.
Backstage intelligence
What makes interactions relevant.
Clinical evidence & approved claims
Surgeon & center intelligence
Procedure & market signals
Product positioning
Competitive intelligence
Faculty & KOL knowledge
AI orchestration, governance & compliance
On-stage interactions
Your customers experience.
Rep & distributor conversations
Medical education & labs
Marketing engagement
Market development outreach
Market access discussions
Executive engagement
Every customer interaction. One intelligent backstage.
Instead of asking every rep, distributor or marketer to research the market from scratch, PangeaGTM turns your existing knowledge and external market intelligence into a shared commercial foundation.
➜ What the organization learns becomes reusable.
➜ What one team discovers strengthens the next interaction.
➜ Backstage intelligence improves every on-stage moment.
BUILT FOR NORTH AMERICAN EXPANSION
From market entry to repeatable adoption
Knowing where to focus first
Which surgeons are most relevant?
Which centers and networks matter?
Which clinical and procedure signals indicate potential?
Which relationships can accelerate adoption?
Which message will resonate with each audience?
PangeaGTM helps turn those questions into a structured commercial process - from market intelligence and targeting through engagement, meetings and continued growth.
Proven in US MedTech execution
A MedTech engagement demonstrated how broad surgeon populations can be progressively qualified into focused commercial targets.
In one execution, thousands of orthopedic surgeons were screened individually across two US states, resulting in substantially smaller groups identified as relevant to the specific clinical and product focus. The approach combined procedure and symptom signals, professional profiles, healthcare networks, KOL relationships and CPT-based research.
For MedTech companies entering or expanding in North America, the challenge is not simply gaining access to a large market.
RESULTS
Business outcomes
1. Accelerate market adoption
Create Identify higher-potential surgeons and treatment centers earlier.
Build a qualified pipeline before and during market launch.
Improve progression from target surgeon to commercial conversation.
Strengthen clinical and commercial differentiation.
Improve the quality and relevance of surgeon engagement.
Accelerate the path from launch to first cases.
Expand into new regions, centers and clinical networks more effectively.
2. Improve commercial efficiency
Focus commercial resources on higher-potential targets.
Reduce manual surgeon research and meeting preparation.
Reuse clinical, product and market knowledge across teams.
Improve alignment across marketing, commercial teams, faculty, reps and distributors.
Keep messaging aligned with approved claims and company positioning.
Shorten the distance between market insight and customer action.
Scale North American growth without requiring every team member to become an expert on every surgeon and market. experts.
PangeaGTM helps MedTech companies accelerate market adoption while improving commercial efficiency.
LETS CONNECT
It provides a shared foundation for how MedTech companies identify the right surgeons, build market relevance, engage credibly, differentiate their innovation and grow adoption.
Interested in exploring what this could mean for your North American growth strategy?
From MedTech tools to connected commercial execution
PangeaGTM works across the systems and teams already supporting your commercial organization.
It connects the clinical knowledge, market intelligence, customer context and decisions that flow between them.
That makes PangeaGTM more than another prospecting or AI content tool.
Better connected GTM. More relevant execution. More scalable growth.
CONTACT US
CONFIDENTIALiTY POLICY
© 2026. All rights reserved.
COMPANY
Pangea Summit
SAS (Société par actions simplifée)
HQ : 50 Avenue des Champs Elysées 75008 Paris, FRANCE
Managing Director: Gerald Poncet
Registration number (RCS): 929 797 868